Veteran UFC fighter C.B. Dollaway has been suspended for two years by USADA after testing positive for multiple banned substances.
USADA (United States Anti-Doping Agency) officials announced the news on Monday after Dollaway was punished in accordance to the UFC’s anti-doping policy.
“Dollaway, 35, tested positive for anastrozole, growth hormone releasing peptide 2 (GHRP-2 or pralmorelin), a metabolite of GHRP-2, and GHRP-6 as the result of an out-of-competition urine sample he provided on December 19, 2018. Anastrozole is a Specified Substance in the class of Hormone and Metabolic Modulators, while GHRP-2 and GHRP-6 are Specified Substances in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics.
“Dollaway also tested positive for clomiphene in an out-of-competition urine sample collected on February 9, 2019.”
Anastrozole is typically used as a treatment for women suffering from breast cancer but in men in can be used to reduce the amount of estrogen produced in the body, which can be a side effect of using other drugs such as steroids or testosterone.
GHRP-2 or pralmorelin is a synthetically produced growth hormone, which can be used to increase endurance as well as numerous other performance enhancing benefits.
Clomiphene has become a common drug found in numerous failed tests with past UFC athletes including Brock Lesnar and Jon Jones. Clomiphene is another drug typically used by women but can be used to spike testosterone production in men.
Dollaway was also busted for using an IV over the allowed limit by athletes competing in the UFC.
“Dollaway received an over-the-limit intravenous (IV) infusion on December 13, 2018,” USADA officials stated. “IV infusions and/or injections of more than 100 mL per 12-hour period are prohibited, except for those legitimately received in the course of hospital treatments, surgical procedures, or clinical diagnostic investigations.”
While Dollaway failed multiple tests over a period of time, USADA ultimately based his suspension on the date of the original failure, which is what kicked off his period of ineligibility.
“Dollaway’s two positive tests and use of an over-the-limit IV were treated as a single, first violation because, after a thorough investigation, it was determined that the positive tests were consistent with ingestion prior to January 11, 2019, the date he received notification of his first positive test,” USADA officials said. “Dollaway’s two-year period of ineligibility began on December 13, 2018.”
That means Dolloway will not be eligible to return to action until after Dec. 13, 2020.
CB Dollaway suspended two years by USADA after testing positive for multiple banned substances
I mean... What more can I say.
USADA (United States Anti-Doping Agency) officials announced the news on Monday after Dollaway was punished in accordance to the UFC’s anti-doping policy.
“Dollaway, 35, tested positive for anastrozole, growth hormone releasing peptide 2 (GHRP-2 or pralmorelin), a metabolite of GHRP-2, and GHRP-6 as the result of an out-of-competition urine sample he provided on December 19, 2018. Anastrozole is a Specified Substance in the class of Hormone and Metabolic Modulators, while GHRP-2 and GHRP-6 are Specified Substances in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics.
“Dollaway also tested positive for clomiphene in an out-of-competition urine sample collected on February 9, 2019.”
Anastrozole is typically used as a treatment for women suffering from breast cancer but in men in can be used to reduce the amount of estrogen produced in the body, which can be a side effect of using other drugs such as steroids or testosterone.
GHRP-2 or pralmorelin is a synthetically produced growth hormone, which can be used to increase endurance as well as numerous other performance enhancing benefits.
Clomiphene has become a common drug found in numerous failed tests with past UFC athletes including Brock Lesnar and Jon Jones. Clomiphene is another drug typically used by women but can be used to spike testosterone production in men.
Dollaway was also busted for using an IV over the allowed limit by athletes competing in the UFC.
“Dollaway received an over-the-limit intravenous (IV) infusion on December 13, 2018,” USADA officials stated. “IV infusions and/or injections of more than 100 mL per 12-hour period are prohibited, except for those legitimately received in the course of hospital treatments, surgical procedures, or clinical diagnostic investigations.”
While Dollaway failed multiple tests over a period of time, USADA ultimately based his suspension on the date of the original failure, which is what kicked off his period of ineligibility.
“Dollaway’s two positive tests and use of an over-the-limit IV were treated as a single, first violation because, after a thorough investigation, it was determined that the positive tests were consistent with ingestion prior to January 11, 2019, the date he received notification of his first positive test,” USADA officials said. “Dollaway’s two-year period of ineligibility began on December 13, 2018.”
That means Dolloway will not be eligible to return to action until after Dec. 13, 2020.
CB Dollaway suspended two years by USADA after testing positive for multiple banned substances
I mean... What more can I say.